Agilent's Pathology Push Just Closed: What the Proscia Integration Can Tell Us

Barchart · 16h ago
Barchart Beat Jan 2026 $1.37 $1.36 -0.73% Miss Apr 2026 $1.40 $1.49 +6.43% Beat Jul 2026 $1.48 $1.62 +9.46% Beat

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Agilent reports after the market close, meaning Day 0 reflects anticipation before results are released, while Day +1 captures the market's first full reaction to the earnings announcement.

Earnings Date Day 0 Move Day 0 Range Day +1 Move Day +1 Range
2026-08-26 +$0.31 (+0.20%) $2.98 (1.93%) +$2.61 (+1.68%) $8.29 (5.35%)
2026-05-27 +$0.76 (+0.66%) $3.38 (2.94%) +$19.54 (+16.87%) $8.30 (7.17%)
2026-02-25 +$0.32 (+0.26%) $2.15 (1.73%) -$3.75 (-3.01%) $9.92 (7.95%)
2025-11-24 +$2.35 (+1.55%) $3.13 (2.07%) +$3.60 (+2.34%) $12.27 (7.99%)
2025-08-27 +$0.39 (+0.33%) $1.69 (1.43%) +$6.27 (+5.28%) $7.22 (6.08%)
2025-05-28 -$0.38 (-0.34%) $1.44 (1.29%) +$2.40 (+2.16%) $3.99 (3.60%)
2025-02-26 +$0.29 (+0.22%) $2.82 (2.10%) -$7.39 (-5.50%) $5.51 (4.10%)
2024-11-25 +$0.65 (+0.49%) $1.85 (1.38%) -$0.12 (-0.09%) $8.64 (6.42%)
Avg Abs Move 0.51% 1.86% 4.62% 6.08%

Historically, Agilent has shown significant post-earnings volatility, with an average absolute Day +1 move of 4.62% and an average Day +1 range of 6.08%. The most dramatic reaction came in May 2026, when the stock surged 16.87% on Day +1 following a strong earnings beat and raised guidance. Other notable moves include a 5.28% gain in August 2025 and a 5.50% decline in February 2025.

Day 0 moves have been relatively muted, averaging just 0.51%, consistent with an after-close reporting schedule where the market has limited time to react before the next trading session. The average Day 0 range of 1.86% reflects modest intraday volatility ahead of results.

The recent trend shows positive Day +1 reactions in three of the last four quarters, with the May 2026 surge standing out as an outlier driven by the combination of a revenue beat, margin expansion, and upgraded full-year guidance. Investors should expect meaningful volatility following this release, particularly given the strong momentum heading into the print and elevated expectations around China, pharma, and margin performance.

Part 2.2: Options Market Expected Move

Metric Value
Expiration Date 12/18/26 (DTE 28)
Expected Move $14.41 (8.48%)
Expected Range $155.55 to $184.37
Implied Volatility 44.45%

The options market is pricing in an expected move of 8.48%, which is notably higher than the stock's average historical Day +1 move of 4.62%. This suggests options traders are anticipating above-average volatility, potentially reflecting uncertainty around the sustainability of recent growth drivers or heightened expectations for guidance commentary heading into fiscal 2027.

Part 3: What Analysts Are Saying

Agilent currently holds a Strong Buy consensus among analysts, with 13 Strong Buy ratings, 1 Moderate Buy, and 6 Hold ratings. There are no Sell or Strong Sell ratings, reflecting broad confidence in the company's growth trajectory and execution.

The average price target stands at $182.79, implying 7.3% upside from the current level. The range of targets spans from a low of $155.00 to a high of $200.00, indicating some divergence in views but with the majority clustering toward the bullish end.

Analyst sentiment has improved over the past month, with the number of Strong Buy ratings increasing from 12 to 13 and Moderate Buys declining from 2 to 1. The average recommendation score of 4.35 (on a scale where 5 is Strong Buy) has ticked up from 4.30 a month ago, signaling growing conviction.

Recent analyst commentary has highlighted "attractive risk-reward" and "broad-based outperformance" as key themes. Several firms have raised price targets following the third-quarter beat, with upgrades citing the Ignite transformation, China recovery, and pharma reshoring as structural tailwinds. One analyst noted that the company's "autonomous lab opportunity and China strategy" support a steady outlook, while another pointed to "efficiency gains from its Ignite program" as a key driver behind improved margins and the raised full-year guidance.

Part 4: Technical Picture

Agilent's Barchart Technical Opinion currently stands at 64% Buy, down from 88% Buy a week ago and 100% Buy a month ago, indicating a recent weakening in technical momentum despite the longer-term uptrend.

  • Short-term (50% Buy): Moderate buy signal suggests near-term momentum has cooled from recent highs
  • Medium-term (50% Buy): Neutral-to-positive reading indicates consolidation in the intermediate timeframe
  • Long-term (100% Buy): Strong buy signal reflects solid strength in the longer-term trend

The trend is characterized as Strong in direction but Weakening in momentum, suggesting the stock may be pausing after a sustained rally heading into earnings.

From a moving average perspective, the stock is trading below its 5-day ($173.64), 10-day ($175.02), 20-day ($175.61), and 50-day ($171.09) moving averages, indicating short-term weakness. However, it remains above its 100-day ($157.18) and 200-day ($138.98) moving averages, confirming the longer-term uptrend remains intact.

Period Value Period Value
5-Day MA $173.64 50-Day MA $171.09
10-Day MA $175.02 100-Day MA $157.18
20-Day MA $175.61 200-Day MA $138.98

The technical setup heading into earnings is mixed: while the longer-term trend remains constructive with the stock well above its 200-day moving average, the recent pullback below shorter-term averages and the decline in the Barchart Opinion signal suggest some near-term caution. The stock has retraced from recent highs, which could provide a more favorable entry point for bulls if the company delivers on expectations. However, the weakening momentum and short-term pressure below key moving averages suggest the stock may be vulnerable to further downside if results or guidance disappoint. Conversely, a strong print could provide the catalyst needed to reclaim short-term moving averages and resume the uptrend.

This article was generated using Barchart’s automated content technology and existing data APIs. As a result, we are able to provide readers with timely, actionable, in-depth analysis on more equities, allowing them to make more informed decisions. All information and data in this article is solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. And, if you would like to report any inaccuracies, please contact news@barchart.com.